Wednesday 14 October 2026 Export ALHC’s income statement to Excel — free account

Alignment Healthcare, Inc.

Alignment Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.9 billion, up 46.1% from fiscal 2024. In the quarter to June 2026, revenue grew 31.6%, EPS grew 125.0%, free cash flow fell 229.5% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

8.30 0.21 +2.60%

Follow ALHC

Alert me

Market cap: $1.7B
P/E: 39.5×
Fwd P/E: 80.3×
Dividend yield: —
F-score: 6/9
Altman Z: 5.52
Beneish M: −2.73
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.20

Total sells 520.64

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	1	—	—	—	—
Sell	3	11	5	3	14	5	2	6	3	2	4	1

Insider Ownership 4.37%

Capital & Financial Ratios $m

Market Cap 1,720.00

Revenue 4,577.33

Net Income 40.70

Free Cash Flow 177.51

Net Debt (377.65)

Current Ratio 1.70

Debt/Equity 1.22

P/E ratio 39.52

Fwd P/E 80.30

P/S ratio 0.38

P/B ratio 6.49

Past 5Y EPS Growth —

This Y EPS Growth 84.76%

Next Y EPS Growth 135.49%

Next Y revenue growth 32.14%

Next 5Y EPS Growth 62.27%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 0.86%

10-year low 10-year high

P/B against its own 10 years 19.73%

10-year low 10-year high

EV/Sales against its own 10 years 0.86%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	319	471	604	702
Receivables	120	154	253	297
Inventory	—	—	—	—
Other	—	—	—	—
	484	662	952	1,160

	2023	2024	2025	Q'26
Payables	229	312	508	645
ST’ Debt	—	—	—	—
Other	—	—	—	—
	263	352	557	683

Compound Annual Growth %

	10y	5y	3y
Sales	—	32.71%	40.16%
Cash Flow	—	79.25%	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	42.41%	(9.18%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	1,235	1,336	—	—	—
’25	927	1,015	994	1,013	3,949
’24	629	681	692	701	2,704
’23	439	462	457	465	1,824
’22	346	366	360	362	1,434
’21	267	309	293	298	1,168
’20	225	244	248	242	959

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	129	(17)	—	—	—
’25	17	29	145	(50)	140
’24	(6)	24	26	(9)	35
’23	85	37	6	(187)	(59)
’22	(12)	10	105	(149)	(45)
’21	(38)	(23)	13	(30)	(79)
’20	(22)	13	26	(10)	8

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	121	(27)	—	—	—
’25	8	21	139	(55)	113
’24	(17)	12	17	(18)	(7)
’23	78	29	(4)	(198)	(95)
’22	(17)	4	99	(156)	(69)
’21	(43)	(28)	7	(33)	(97)
’20	(25)	10	22	(15)	(8)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	0.05	0.17	—	—	—
’25	(0.05)	0.07	0.02	(0.05)	0.00
’24	(0.25)	(0.13)	(0.14)	(0.16)	(0.67)
’23	(0.20)	(0.15)	(0.19)	(0.25)	(0.79)
’22	(0.23)	(0.06)	(0.22)	(0.31)	(0.83)
’21	(0.37)	(0.25)	(0.26)	(0.27)	(1.14)
’20	(0.07)	0.05	0.07	(0.20)	(0.15)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	—	—	11.95	6.14	4.88	4.46	11.30	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	—	—	28.59	19.17	13.05	14.25	21.06
People
People	Employees	—	—	—	—	775	847	1,037	1,536	1,679	1,849
	Revenue/emp, $m	—	—	—	0.00	1.24	1.38	1.38	1.19	1.61	2.14
Income, $m
Income, $m	Revenue	—	—	—	757	959	1,168	1,434	1,824	2,704	3,949
	Gross margin, %	—	—	—	12.63	17.33	11.02	12.85	11.02	10.97	12.37
	EBT	—	—	—	(45)	(23)	(195)	(149)	(148)	(128)	(1)
	EBT margin, %	—	—	—	(5.91)	(2.39)	(16.72)	(10.41)	(8.13)	(4.74)	(0.02)
	Net income	—	0	—	(45)	(23)	(195)	(150)	(148)	(128)	(1)
	Depreciation	—	—	—	19	18	18	19	18	26	31
Per share, $
Per share, $	Revenue	—	—	—	5.57	6.31	6.79	7.91	9.79	14.17	19.94
	Earnings	—	—	—	(0.33)	(0.15)	(1.14)	(0.83)	(0.79)	(0.67)	0.00
	Cash flow	—	—	—	0.07	0.05	(0.46)	(0.25)	(0.32)	0.18	0.71
	Capex	—	—	—	(0.08)	(0.10)	(0.11)	(0.13)	(0.19)	(0.22)	(0.13)
	Free cash flow	—	—	—	(0.01)	(0.05)	(0.56)	(0.38)	(0.51)	(0.03)	0.57
	Book value	—	—	—	(0.58)	0.20	1.78	1.32	0.85	0.53	0.91
	Shares, m	—	—	—	136	152	172	181	186	191	198
Valuation, ×
Valuation, ×	P/E	—	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	—	—	—	2.75	2.75	2.07	1.47	0.87	0.79	0.99
	P/B	—	—	—	86.03	86.03	7.90	8.79	10.00	21.26	21.81
	EV/Sales	—	—	—	2.68	2.68	1.80	1.29	0.78	0.74	0.92
	EV/FCF	—	—	—	(319.41)	(319.41)	(21.64)	(26.81)	(14.96)	(301.30)	32.07
Cash, $m
Cash, $m	Operating cash flow	—	—	—	9	8	(79)	(45)	(59)	35	140
	Capex	—	—	—	(10)	(16)	(18)	(24)	(36)	(41)	(27)
	Free cash flow	—	—	—	(1)	(8)	(97)	(69)	(95)	(7)	113
Balance, $m
Balance, $m	Working capital	—	—	—	(3)	111	386	315	221	310	395
	Total debt	—	—	—	138	144	151	161	162	321	323
	Net debt	—	—	—	51	(63)	(316)	(249)	(157)	(149)	(281)
	Shareholders’ equity	—	—	—	(79)	31	306	239	158	101	179
Returns, %
Returns, %	ROA	—	—	—	(46.25)	(8.62)	(40.29)	(23.65)	(24.15)	(18.64)	(0.08)
	ROIC	—	—	—	0.00	0.00	0.00	0.00	(7,493.96)	0.00	0.00
	ROE	—	—	—	186.00	95.33	(116.01)	(54.84)	(74.50)	(98.86)	(0.52)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
ELV Elevance Health, Inc.	$91.5B	18.8×	20.3×	+1.40% (above 0%: growing)	−13.08% (below 0%: shrinking)	−9.01% (below 0%: shrinking)	15.77%	4.56%	Compare
CI Cigna Group	$74.9B	11.7×	11.4×	+6.68% (above 0%: growing)	+10.16% (above 0%: growing)	+66.93% (above 0%: growing)	88.24%	3.73%	Compare
HUM Humana Inc.	$52.1B	39.5×	42.9×	+26.18% (above 0%: growing)	+27.88% (above 0%: growing)	+58.51% (above 0%: growing)	13.45%	3.33%	Compare
CNC Centene Corporation	$33.1B	— (loss-making)	24.8×	+9.92% (above 0%: growing)	n/m	+116.61% (above 0%: growing)	8.59%	2.24%	Compare
MOH Molina Healthcare, Inc	$10.7B	— (loss-making)	55.0×	−4.84% (below 0%: shrinking)	−74.95% (below 0%: shrinking)	+5.81% (above 0%: growing)	13.19%	1.33%	Compare
OSCR Oscar Health, Inc.	$10.5B	19.8×	29.7×	+70.40% (above 0%: growing)	n/m	+316.29% (above 0%: growing)	22.25%	7.96%	Compare
CLOV Clover Health Investments, Corp.	$2.5B	— (loss-making)	292×	+55.60% (above 0%: growing)	n/m	+406.43% (above 0%: growing)	20.59%	3.77%	Compare
PGNY Progyny, Inc.	$2.2B	28.2×	19.9×	+5.30% (above 0%: growing)	+80.00% (above 0%: growing)	−12.01% (below 0%: shrinking)	25.48%	11.41%	Compare
ALHC Alignment Healthcare, Inc.	$1.7B	39.5×	80.3×	+31.55% (above 0%: growing)	+125.00% (above 0%: growing)	−229.51% (below 0%: shrinking)	13.55%	3.15%
Median of peers	$21.9B	19.8×	27.3×	+8.30%	+10.16%	+62.72%	18.18%	3.75%

All 12 Healthcare Plans stocks →

Alignment Healthcare, Inc. (ALHC) key facts

Strength: Alignment Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.9 billion, up 46.1% from fiscal 2024.
Alignment Healthcare, Inc. (ALHC) is a Healthcare Plans company in the Healthcare sector, listed on Nasdaq.
As of October 13, 2026, ALHC traded at $8.30, a market capitalization of $1.7 billion.
Return on equity was −0.52% and debt-to-equity 1.22.
Its Piotroski F-score is 6 out of 9 and its Altman Z-score is 5.52 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.